341 related articles for article (PubMed ID: 29072955)
1. Imaging of Hepatocellular Carcinoma Response After
Semaan S; Makkar J; Lewis S; Chatterji M; Kim E; Taouli B
AJR Am J Roentgenol; 2017 Nov; 209(5):W263-W276. PubMed ID: 29072955
[TBL] [Abstract][Full Text] [Related]
2. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
[TBL] [Abstract][Full Text] [Related]
3. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.
Reiner CS; Morsbach F; Sah BR; Puippe G; Schaefer N; Pfammatter T; Alkadhi H
J Vasc Interv Radiol; 2014 May; 25(5):747-59. PubMed ID: 24630751
[TBL] [Abstract][Full Text] [Related]
4. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
5. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
[TBL] [Abstract][Full Text] [Related]
6. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.
Kousik V; Promila P; Verma R; Gupta A
Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180
[TBL] [Abstract][Full Text] [Related]
7. Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma.
Iñarrairaegui M; Martinez-Cuesta A; Rodríguez M; Bilbao JI; Arbizu J; Benito A; Alegre F; D'Avola D; Herrero JI; Quiroga J; Prieto J; Sangro B
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1441-8. PubMed ID: 20056355
[TBL] [Abstract][Full Text] [Related]
8. Superselective yttrium-90 radioembolization for hepatocellular carcinoma in high-risk cases: another tool in the toolbox.
Brown KT
J Vasc Interv Radiol; 2014 Jul; 25(7):1073-4. PubMed ID: 24968727
[No Abstract] [Full Text] [Related]
9. 90Y Liver Radioembolization Imaging Using Amplitude-Based Gated PET/CT.
Osborne DR; Acuff S; Neveu M; Kaman A; Syed M; Fu Y
Clin Nucl Med; 2017 May; 42(5):373-374. PubMed ID: 28240669
[TBL] [Abstract][Full Text] [Related]
10. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
11. MDCT necrosis quantification in the assessment of hepatocellular carcinoma response to yttrium 90 radioembolization therapy: comparison of two-dimensional and volumetric techniques.
Galizia MS; Töre HG; Chalian H; McCarthy R; Salem R; Yaghmai V
Acad Radiol; 2012 Jan; 19(1):48-54. PubMed ID: 22054801
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activity assessment by
Kim DY; Lee HW; Kang W; Kim GM; Won JY; Yun M
J Gastroenterol Hepatol; 2021 Jun; 36(6):1679-1684. PubMed ID: 33226706
[TBL] [Abstract][Full Text] [Related]
13. [Radioembolization with (90)Y-microspheres for liver tumors].
Rodríguez-Fraile M; Iñarrairaegui M
Rev Esp Med Nucl Imagen Mol; 2015; 34(4):244-57. PubMed ID: 25911062
[No Abstract] [Full Text] [Related]
14. Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis.
Kokabi N; Camacho JC; Xing M; Qiu D; Kitajima H; Mittal PK; Kim HS
Abdom Imaging; 2014 Oct; 39(5):969-78. PubMed ID: 24740759
[TBL] [Abstract][Full Text] [Related]
15. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
[TBL] [Abstract][Full Text] [Related]
16. Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres.
Keppke AL; Salem R; Reddy D; Huang J; Jin J; Larson AC; Miller FH
AJR Am J Roentgenol; 2007 Mar; 188(3):768-75. PubMed ID: 17312067
[TBL] [Abstract][Full Text] [Related]
17. Yttrium 90 Radioembolization for Hepatocellular Carcinoma.
Howerton L
Radiol Technol; 2021 Nov; 93(2):197-215. PubMed ID: 34728580
[TBL] [Abstract][Full Text] [Related]
18. Yttrium-90 Transarterial Radioembolization: An Effective Primary or Salvage Therapy to Bridge the Patients with Hepatocellular Carcinoma to Liver Transplantation.
Qu X; Zhang F
Acad Radiol; 2024 May; 31(5):1836-1838. PubMed ID: 38472023
[No Abstract] [Full Text] [Related]
19. Quantitative Imaging Biomarkers for
Schobert I; Chapiro J; Nezami N; Hamm CA; Gebauer B; Lin M; Pollak J; Saperstein L; Schlachter T; Savic LJ
J Nucl Med; 2019 Aug; 60(8):1066-1072. PubMed ID: 30655331
[TBL] [Abstract][Full Text] [Related]
20. Prediction of hepatocellular carcinoma response to
Gordic S; Wagner M; Zanato R; Hectors S; Besa C; Kihira S; Kim E; Taouli B
Cancer Imaging; 2019 May; 19(1):29. PubMed ID: 31142363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]